AB
AGIO icon

Amalgamated Bank’s Agios Pharmaceuticals AGIO Stock Holding History

Amalgamated Bank’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,774
Closed -$48K – 1647
2025
Q4 		$48K Sell
1,774
-183
-9% -$6.42K ﹤0.01% 1847
2025
Q3 		$79K Hold
1,957
– – ﹤0.01% 1736
2025
Q2 		$65K Hold
1,957
– – ﹤0.01% 1775
2025
Q1 		$57K Buy
1,957
+7
+0.4% +$232 ﹤0.01% 1774
2024
Q4 		$64K Hold
1,950
– – ﹤0.01% 1782
2024
Q3 		$87K Hold
1,950
– – ﹤0.01% 1728
2024
Q2 		$84K Buy
1,950
+83
+4% +$3K ﹤0.01% 1750
2024
Q1 		$55K Sell
1,867
-2,972
-61% -$79.6K ﹤0.01% 1843
2023
Q4 		$108K Sell
4,839
-556
-10% -$12.5K ﹤0.01% 1970
2023
Q3 		$134K Hold
5,395
– – ﹤0.01% 1910
2023
Q2 		$153K Sell
5,395
-374
-6% -$9.31K ﹤0.01% 1920
2023
Q1 		$133K Sell
5,769
-1,291
-18% -$34.3K ﹤0.01% 1940
2022
Q4 		$198K Buy
7,060
+97
+1% +$2.73K ﹤0.01% 1868
2022
Q3 		$197K Buy
6,963
+68
+1% +$1.82K ﹤0.01% 1857
2022
Q2 		$153K Buy
6,895
+339
+5% +$7.66K ﹤0.01% 1982
2022
Q1 		$191K Sell
6,556
-738
-10% -$22.6K ﹤0.01% 1955
2021
Q4 		$240K Sell
7,294
-424
-5% -$17.1K ﹤0.01% 1907
2021
Q3 		$356K Sell
7,718
-934
-11% -$45.1K ﹤0.01% 1765
2021
Q2 		$477K Buy
8,652
+1,107
+15% +$61.9K ﹤0.01% 1670
2021
Q1 		$390K Sell
7,545
-558
-7% -$27.6K 0.01% 1116
2020
Q4 		$351K Sell
8,103
-4
-0% -$158 0.01% 1145
2020
Q3 		$284K Sell
8,107
-13
-0.2% -$570 0.01% 1135
2020
Q2 		$434K Sell
8,120
-5,147
-39% -$238K 0.02% 912
2020
Q1 		$471K Sell
13,267
-179
-1% -$8.27K 0.01% 940
2019
Q4 		$642K Buy
13,446
+2,861
+27% +$108K 0.01% 993
2019
Q3 		$343K Buy
10,585
+113
+1% +$4.68K 0.01% 1235
2019
Q2 		$522K Sell
10,472
-942
-8% -$50.3K 0.01% 1048
2019
Q1 		$770K Buy
11,414
+185
+2% +$10.8K 0.02% 809
2018
Q4 		$518K Buy
11,229
+4,112
+58% +$254K 0.01% 903
2018
Q3 		$549K Sell
7,117
-4,550
-39% -$366K 0.01% 900
2018
Q2 		$983K Buy
11,667
+1,194
+11% +$104K 0.02% 767
2018
Q1 		$856K Buy
10,473
+2,186
+26% +$169K 0.02% 757
2017
Q4 		$474K Buy
8,287
+460
+6% +$28.9K 0.01% 1011
2017
Q3 		$522K Buy
7,827
+897
+13% +$53.9K 0.02% 923
2017
Q2 		$357K Buy
6,930
+2,407
+53% +$123K 0.01% 1099
2017
Q1 		$264K Sell
4,523
-1,002
-18% -$48K 0.01% 1218
2016
Q4 		$231K Buy
5,525
+772
+16% +$40.5K 0.01% 1307
2016
Q3 		$251K Buy
+4,753
New +$207K 0.01% 1124
2015
Q4 		– Sell
-3,021
Closed -$213K – 1207
2015
Q3 		$213K Buy
3,021
+44
+1% +$4.3K 0.02% 1113
2015
Q2 		$331K Buy
+2,977
New +$321K 0.03% 890

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Amalgamated Bank's AGIO Position: Q1 2026 in Review

Amalgamated Bank sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 1,774 shares — an estimated $48K sold.

Amalgamated Bank first reported a position in AGIO in Q2 2015 and held it in 40 quarters. The position peaked at $983K in Q2 2018. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Amalgamated Bank reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,774 Agios Pharmaceuticals shares in Q1 2026, an estimated $48K.
  • Amalgamated Bank first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 40 quarters.
  • Amalgamated Bank's Agios Pharmaceuticals position peaked at $983K in Q2 2018.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.